GlassScriptPhysician profile
Sarika S Tripathi
NPI 1215987268
$1,276.28
in general payments reported to CMS, 2019-2025
18 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $31.70 · 2021: $229 · 2022: $452 · 2023: $246 · 2024: $92.29 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $240.64 | 2021-2023 | Nuzyra |
| Organogenesis INC. | $200.22 | 2022-2025 | Affinity, Via Matrix |
| Smith+Nephew, INC. | $161.99 | 2021-2025 | Grafix, Renasys Go V2 Home, Oasis |
| Abbvie INC. | $128.60 | 2021-2023 | Dalvance |
| Allergan, INC. | $114.98 | 2019 | |
| Kci USA, INC. | $71.66 | 2021 | |
| Philips North America LLC | $67.39 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $43.46 | 2023-2024 | Farxiga |
| Innovation Technologies INC | $40.28 | 2022 | |
| Melinta Therapeutics, LLC | $36.94 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $33.38 | 2020-2022 | |
| Next Science LLC | $31.14 | 2023 | Blastx, Xperience, Surgx |
| Kerecis Limited | $22.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Convatec INC. | $20.76 | 2022 | |
| Nabriva Therapeutics, Plc | $18.45 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $14.89 | 2022 | |
| Molnlycke Health Care US, LLC | $14.85 | 2023 | Exufiber Ag+, Mepilex Border Flex, Mepilex Xt |
| Tactile Systems Technology INC | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarika Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.